Overview: Explaining the concept of conditional knockout (CKO) models, which enable gene knockout in a specific temporal or spatial patte, allowing for more focused and accurate research.
Tab 1 CKO
Conditional Gene Knockout Techniques
Site-Specific Recombinase Systems: Mainly achieved through systems like Cre-LoxP, FLP-Frt, and Dre-Rox, with Cre-LoxP being the most frequently used.
Flox Mouse Models: A LoxP sequence is placed at each end of a DNA sequence to be deleted, generating a Flox (flanked by LoxP) mouse. Flox mice are then crossed with Cre-expressing mice for tissue- or cell-specific gene knockout.
Advantages of CKO Models
Reduced Lethality Risks: Flox mice may be less likely to develop embryonic or neonatal lethality compared to conventional knockout models.
Flexibility: By crossing with different Cre-expressing mice, offsprings can be generated in which the target gene is inactivated at any developmental stage or in any specific cell type.
Timeframe for CRISPR Gene Editing
It typically takes 6-9 months to generate a conditional gene knockout mouse model using CRISPR gene editing technology.
Tab 2 Systems
Cre-lox System
Efficiency: Characterized by simple manipulation and high efficiency, the Cre-lox system is a powerful tool for gene editing.
Applications: Allows for time-specific knockout and knock-in of target genes, thereby enabling spatiotemporal regulation of genes .
Recombination Events in Cre-lox System
Deletion: Occurs if the two loxP sites are in the same orientation.
Inversion: Happens if the loxP sites are in opposite orientations.
Translocation: If there's a floxed donor sequence, it can be swapped with the original sequence.
Wild-type LoxP site and its permutations
Cre Recombination Mechanism
Figure 2: Illustrating the structure of loxP sites and the Cre recombinase-mediated cassette exchange, inversion, and excision.
Steps in Establishing Conditional Gene Targeting
Cre-expressing Mouse Strain: Driven by specific promoters, Cre recombinase can function in specific cells, tissues, or the whole body.
Flox Mouse Strain: Established by flanking the target gene with lox sites. The conditional gene targeting strain is achieved by crossing Cre-expressing and Flox mouse strains.
Conditional Gene Activation and Knock-Out
Gene Activation: Utilizing the Lox-Stop-Lox (LSL) stop cassette for cell type-specific gene activation.
Gene Knock-Out: Achieving conditional gene knockout by flanking the target gene with lox sites in the same orientation.
Inducible Cre-lox Systems
CreER-lox System (Tamoxifen-Inducible): The CreER-lox system, often referred to as the Tamoxifen (Tam)-inducible Cre system, is a sophisticated method for achieving controlled genetic recombination. This system hinges on the fused protein of Cre recombinase and the estrogen receptor (ER), creating a mechanism sensitive to the presence of Tamoxifen.
Mechanism of Action
In Absence of Tamoxifen: The CreER protein, in its default state, is localized in the cytosol and remains bound to the heat shock protein 90 (HSP90).
Upon Tamoxifen Administration: The interaction between CreER and HSP90 is disrupted due to the presence of Tamoxifen. This disruption triggers a series of events leading to the nuclear translocation of CreER.
Inside the Nucleus: Once in the nucleus, CreER can accurately identify and bind to loxP sites within the genome. This binding enables the specific inactivation of a targeted gene, referred to as gene X, in a particular tissue, denoted as tissue Y.
Advantages: CreER2, a variant of this system, is known for its heightened sensitivity to Tamoxifen, making it a more effective tool for in vivo drug induction and gene modulation.
Tetracycline (Tet) System: Overview: The Tetracycline (Tet) system, also known as the doxycycline (Dox)-inducible Cre system, operates in two modes: Tet-on and Tet-off, allowing for Dox-dependent gene activation and inactivation. This system includes reverse tetracycline-controlled transactivator (rtTA), tetracycline-controlled transactivator (tTA), and tetracycline responsive element (TRE) or tetracycline operon (TetO), which regulate Cre gene expression.
Tet-on System Functionality: In the absence of Dox, the inactivated rtTA cannot bind to the TRE sequence, disabling Cre expression. Upon Dox administration, Dox binds to rtTA, activating it. This activation leads to the binding of activated rtTA to the TRE sequence, inducing Cre expression.
Tet-off System
Mechanism: Without Dox, activated tTA can bind to the TRE sequence upstream of Cre, inducing its expression. The presence of Dox inactivates tTA, disrupting its binding to TRE and thus inhibiting Cre expression.
Tab 3 ES cell targeting
It usually takes 9-12 months to generate a conditional gene knock-in mouse model by ES cell targeting technology.
Wild Type Allele: The top line represents a wild-type allele with exons numbered 1 to 4.
Targeting Vector: Below this is a targeting vector indicating the DNA sequence used for homologous recombination. It includes:
LoxP sites (green triangles) that mark the DNA sequence to be removed.
FRT sites (yellow ovals) flanking a neomycin resistance gene (Neo), which is used to select for cells that have incorporated the targeting vector.
A Diphtheria toxin A (DTA) expression cassette is also shown at the end, which serves as a negative selection marker to eliminate cells that have randomly integrated the targeting vector without homologous recombination.
Targeted Allele: The targeting vector recombines with the wild-type allele at the homologous sequences, replacing exon 2 with the Neo cassette flanked by FRT sites and adding LoxP sites flanking exons 2 and 3. This is the targeted allele after homologous recombination.
Cross with FLP Transgenic Mice: This step shows the result of crossing the mouse with the targeted allele with FLP recombinase-expressing mice. The FLP recombinase recognizes FRT sites and removes the Neo cassette, resulting in the Flox allele, which has exons 2 and 3 flanked by LoxP sites.
Cross with Cre Transgenic Mice: Finally, the Flox allele is crossed with Cre recombinase-expressing mice. Cre recombinase recognizes the LoxP sites and excises the DNA between them. This results in the mutant allele, where exon 2 is removed.
Keywords/Tags
Conditional Gene Knockout,KO,Gene Editing Techniques,Recombinase Systems,Genetic Engineering in Mice